Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Clinical trial NCT00112476 · COMPLETED

Trial details

NCT number: NCT00112476
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Recurrent Renal Cell Cancer Stage IV Melanoma Stage IV Renal Cell Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-03-01
Primary completion: 2010-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.